A repost from yesterday for new investors
ARRY IS THE NEXT AMGN !!!!!!!!!!!!!!!
Dr. Snitman, 59, is a Co-Founder of Array and has served as our Chief Operating Officer, our Vice President of Business Development and a member of our Board of Directors since May 1998. Prior to forming Array, Dr. Snitman held various positions with Amgen Inc. since December 1981, including Associate Director, New Products and Technology and Manager of Amgen's Boulder research facility. Dr. Snitman received a B.S. in Chemistry from Northeastern University and a Ph.D. in the Synthesis of Natural Products from the University of Colorado, and was a National Institutes of Health Postdoctoral Fellow at the Massachusetts Institute of Technology. Less
yes both are correct, consider yourselves on the cutting edge of a long run. When more people find out about ARRYs technology and alliances not to mention management and staff, they will be sold on ARRY.